Clinical AI Model Validation and Auditing

We prepare comprehensive validation packages aligned with FDA SaMD, EU MDR, and ISO 13485 requirements, reducing submission cycles and addressing regulator questions preemptively. Our structured evidence demonstrates safety and efficacy for faster clearance.

Our adversarial testing against real-world datasets uncovers performance degradation, bias, and edge-case failures before patient impact. We provide actionable remediation plans to harden your model, ensuring reliability in diverse clinical settings.

We conduct rigorous algorithmic fairness audits using frameworks like Aequitas, testing for disparate impact across demographic subgroups. Our tuning recommendations improve equity and generalizability, building trust with clinicians and patients.

Our validation establishes key performance indicators (KPIs) and statistical process control limits for continuous post-market surveillance. This enables proactive drift detection and performance management, a core requirement of the EU AI Act.

We deliver clear, auditable documentation of the validation lifecycle—from data provenance to final model performance—creating a single source of truth for your AI governance council. This simplifies internal reviews and investor due diligence.

Independent, third-party validation from our experts provides a defensible layer of due diligence. This documented rigor protects your organization against potential litigation and supports insurance underwriting for AI-based medical devices.

Comprehensive performance and documentation audits aligned with FDA SaMD, EU MDR, and ISO 13485 frameworks to prepare your model for regulatory submission and market approval.

Rigorous testing against diverse, multi-site clinical datasets to evaluate model generalizability, identify performance drift, and validate efficacy in target deployment environments.

Quantitative analysis for disparate impact across protected patient subgroups (race, gender, age) using frameworks like NIST AI RMF to ensure equitable model performance and mitigate legal risk.

Systematic identification and risk assessment of potential clinical harm scenarios, including edge cases and adversarial inputs, to build robust safeguards and contingency plans.

Generation of clinician-facing model explanations (e.g., saliency maps, feature importance) and technical documentation to build trust and support clinical decision-making.

Architecture of automated pipelines for ongoing model performance surveillance, data drift detection, and trigger-based re-validation to maintain compliance post-deployment. Learn more about our Healthcare AI Compliance and Governance Consulting.